Moderna, Inc. is a biotechnology company that is focused on creating a transformative medicines based on messenger RNA (mRNA). The Company’s mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane, or secreted proteins that have a therapeutic or preventive benefit with the potential to address a range of spectrum of diseases. The Company develops technologies that enable the development of mRNA medicines for diverse applications. The Company has created modalities, including Prophylactic vaccines, Systemic secreted and cell surface therapeutics, Cancer vaccines, Intratumoral immuno-oncology, Localized regenerative therapeutics, and Systemic intracellular therapeutics. Its diverse development pipeline which consists of 27 development candidates across its 24 programs.
BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. It develops a broad product pipeline using different scientific approaches and technology platforms, including individualized mRNA-based product candidates, chimeric antigen receptor T-cells, checkpoint immunomodulators, targeted cancer antibodies and small molecules. In addition, the Company offers diagnostic products and drug discovery services for other therapeutic areas, including infectious diseases, allergies and autoimmune disorders.
Veuve Doussot’s 2016 ‘Ernestine’ is another exquisite example of the beauty and finesse of vintage Champagne. Made of Pinot Noir and Chardonnay, this lovely sparkler possesses aromatics of apple pie, white flower, salted caramel, and hazelnut. The palate is rich and full, with notes of creamy honey, buttery brioche, and dried apricots.
Terroir and Cellar Notes
The ‘Cuvee’ is an exceptional Champagne produced only in years when the harvest is of such high quality that Veuve Doussot declares it a vintage. Its robust structure comes from the 25-year-old Pinot Noir vines planted in Kimmeridgian-clay soils. Located on 17.30 acres in the Cote des Bar region of southern Champagne, these soils, rich in clay and limestone, are perfectly suited to cultivating Pinot Noir. These soils bring freshness and minerality to the final wine. The addition of Chardonnay contributes crispness and balance to this great vintage. The wine is aged 36 months “sur lattes” in the Veuve Doussot cellars.
Blend: 70% Pinot Noir, 30% Chardonnay
Moon Mountain District is nestled high above Sonoma Valley, near the border with Napa Valley and the Mayacamas Mountains. The altitude, solar radiation and relentless winds off the bay all contribute to producing the famous, small, thick skinned berries with amazing color and concentration of flavor.
Girl with a Pearl Earring is an oil painting by Dutch Golden Age painter Johannes Vermeer, dated c. 1665. Going by various names over the centuries, it became known by its present title towards the end of the 20th century after the earring worn by the girl portrayed there.
Stock outperforms market on strong trading day
Shares of Morgan Stanley MS, +0.40% inched 0.40% higher to $92.05 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX, +0.19% rising 0.19% to 4,247.44 and the Dow Jones Industrial Average DJIA, +0.04% rising 0.04% to 34,479.60. The stock’s rise snapped a four-day losing streak. Morgan Stanley closed $2.22 below its 52-week high ($94.27), which the company achieved on June 7th.
The stock demonstrated a mixed performance when compared to some of its competitors Friday, as JPMorgan Chase & Co. JPM, -0.07% fell 0.07% to $160.29, Bank of America Corp. BAC, +0.41% rose 0.41% to $41.86, and Citigroup Inc. C, -0.53% fell 0.53% to $76.48. Trading volume (6.3 M) remained 3.4 million below its 50-day average volume of 9.7 M.
Published: June 11, 2021 at 5:09 p.m. ET
Clos des Quatre Vents hails from the reputable Margaux appellation and showcases an exemplary fruit-driven yet balanced Bordeaux blend. The Cabernet Sauvignon dominant 2018 vintage provides a powerful nose of black currant, complemented by notes of deep plum and newly ripened fig from the addition of Merlot. The wine is aged in new French oak for 18 months, lending a generous complexity of dried herbs and toasty spice that makes it perfect alongside slow-roasted meats or savory mushroom risotto.
Aging: 18 months in 100% new French oak
Blend: 60% Cabernet Sauvignon, 40% Merlot
Our eponymous wine: Clos des Quatre Vents. It comes from a plot of old vines at the top of a hill on Margaux appellation and enjoys a perfect exposure to the four winds. All these perfect conditions provide a concentrated wine with freshness and pure sensation.
The Clos des Quatre Vents is greedy on the nose, firstly black licorice tainted with ripe fruit. The mouth is round, a soft attack with black cherries and fresh blackcurrant. In the end, the finish is harmonious and silky.
[Information provided by DHI Selections]
Shares of Intelligent Systems INS, +0.57% have been on an absolute tear lately. Shares are up more than 150% year-to-date since Jan. 1, and more than 500% in the last year! That’s because this yet-unprofitable small-cap stock has seen equally impressive revenue growth thanks to its payment processing technology.
CoreCard is a leading issuer-processor and provider of card management and transaction processing systems. CoreCard offers an array of account management and system of record solutions to support the complex requirements of the evolving global financial services industry.
The CoreCard platform provides the market’s most feature-rich design for card processing and managing accounts. The platform supports a full range of card products including prepaid/stored-value, fleet, revolving credit, loans, pay-day lending, debit, commercial, government, healthcare and private-label cards.
Second-quarter profit rose to 44 percent by $5.98 per share price, compared with $3.95 per share. Total revenue rose around 19 percent to $9.4 billion.
Yeah it’s true this is what Brad Pitt does all day and he makes a lot a fucking money doing it…